The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 681.40
Bid: 682.40
Ask: 682.80
Change: -1.40 (-0.21%)
Spread: 0.40 (0.059%)
Open: 691.00
High: 692.60
Low: 680.40
Prev. Close: 682.80
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible Securities - Price Adjustment

11 Dec 2015 08:52

RNS Number : 7669I
Standard Chartered PLC
11 December 2015
 



Standard Chartered PLC

11 December 2015

NOT FOR DISTRIBUTION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES

Notice of adjustment of the Conversion Price of U.S.$2,000,000,000 Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities (Rule 144A ISIN: US853254AT77; Regulation S ISIN: USG84228CE61) (the "Securities")

Please be advised that further to (i) its announcement dated 30 March 2015 in relation to the issuance of the Securities, and (ii) its announcement dated 3 November 2015, prospectus dated 18 November 2015, supplementary prospectus dated 1 December 2015 and announcement dated 11 December 2015 (the "Rights Issue Results Announcement"), all in relation to the 2 for 7 rights issue of 728,432,451 new Ordinary Shares at 465 pence each (the "Rights Issue"), Standard Chartered PLC has, in accordance with the terms and conditions of the Securities (the "Terms and Conditions"), given notice to the Securityholders that the Conversion Price per Ordinary Share in respect of the Securities has been adjusted in accordance with the Terms and Conditions (the "Adjustment"). The Adjustment became effective on 23 November 2015 (the "Effective Date"). Prior to the Effective Date, the Conversion Price per Ordinary Share was U.S.$11.424. The adjusted Conversion Price per Ordinary Share, computed in accordance with Condition 7(e)(iv) of the Terms of Conditions, is U.S.$10.865.

Capitalised terms not otherwise defined in this announcement shall have the meanings given to them in the Terms and Conditions.

For further information with respect to the adjustment of the Conversion Price of the Securities, please paste the following URL into the address bar of the browser:

http://www.rns-pdf.londonstockexchange.com/rns/7669I_-2015-12-11.pdf

For further information, please contact:

James Hopkinson, Head of Investor Relations +44 (0)20 7885 7151

Jon Tracey, Global Head of Communications +44 (0)20 7885 7613

Shaun Gamble, Director, Media Relations +44 (0)20 7885 5934

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement does not constitute an offer of any securities for sale.

The Securities and any ordinary shares which may be delivered upon conversion of the Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act").

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

This announcement has been prepared solely for information purposes and is not an offer (or a solicitation of an offer) to buy or sell any securities in any jurisdiction.

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTBBRTMBIBMIA
Date   Source Headline
12th Mar 20246:00 pmRNSTransaction in Own Shares
12th Mar 20242:54 pmRNSDirector/PDMR Shareholding
12th Mar 202410:57 amRNSOverseas Regulatory Announcement - Grant of awards
12th Mar 202410:00 amRNSStandard Chartered: Management Team Change
11th Mar 20246:23 pmRNSTransaction in Own Shares
8th Mar 20245:59 pmRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20246:02 pmRNSTransaction in Own Shares
6th Mar 202411:33 amRNSNotice of Redemption
5th Mar 20246:15 pmRNSTransaction in Own Shares
4th Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 20245:50 pmRNSTransaction in Own Shares
1st Mar 202412:00 pmRNSTotal Voting Rights
29th Feb 20246:15 pmRNSTransaction in Own Shares
29th Feb 20244:21 pmRNSPublication of Final Terms
29th Feb 20247:00 amRNSIssuance of U.S.$1bn Additional Tier 1 Securities
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20246:09 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSShare Buy-Back
23rd Feb 20242:39 pmRNSFull Year 2023 Pillar 3 Disclosures
23rd Feb 202412:13 pmRNSPublication of Supplementary Prospectus
23rd Feb 20247:00 amRNSAnnual Report 2023
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 2
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 1
23rd Feb 20247:00 amRNSSCPLC Final Results 2023
16th Feb 202410:00 amRNSDirectorate Changes
8th Feb 202411:07 amRNSOverseas Regulatory Announcement
1st Feb 202410:26 amRNSTotal Voting Rights
26th Jan 202412:28 pmRNSDirector/PDMR Shareholding
17th Jan 202412:33 pmRNSPublication of Final Terms
5th Jan 202412:04 pmRNSPublication of Final Terms
2nd Jan 20243:33 pmRNSTotal Voting Rights
28th Dec 202311:22 amRNSPublication of Supplementary Prospectus
27th Dec 202312:36 pmRNSNotice of Redemption
21st Dec 20231:00 pmRNSDirectorate Change
1st Dec 202311:56 amRNSBlock listing Interim Review
1st Dec 202310:37 amRNSTotal Voting Rights
29th Nov 20231:42 pmRNSSCPLC Sustainability Investor Event
22nd Nov 20239:17 amRNSOverseas Regulatory Announcement
21st Nov 202310:28 amRNSOverseas Regulatory Announcement - Grant of Awards
9th Nov 202310:01 amRNSNotice of Redemption
8th Nov 20239:00 amRNSNotice of Redemption
6th Nov 20236:30 pmRNSTransaction in Own Shares
3rd Nov 20236:00 pmRNSTransaction in Own Shares
3rd Nov 202312:28 pmRNSPublication of Final Terms
3rd Nov 202312:05 pmRNS3Q 2023 Pillar 3 Disclosures
2nd Nov 20236:10 pmRNSTransaction in Own Shares
2nd Nov 20232:08 pmRNSSC completes sale of aviation leasing business
1st Nov 20235:53 pmRNSTransaction in Own Shares
1st Nov 202311:38 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.